Page last updated: 2024-10-16

carbon monoxide and Ductus Arteriosus, Patent

carbon monoxide has been researched along with Ductus Arteriosus, Patent in 4 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baragatti, B2
Sodini, D2
Uematsu, S1
Coceani, F2
Brizzi, F1
Barogi, S1
Laubach, VE1
Shesely, EG1
Regan, RF1
Smith, GC1
Tala, P1
Poppius, H1
Siltanen, P1
Heinonen, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial[NCT03022253]Phase 344 participants (Anticipated)Interventional2016-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for carbon monoxide and Ductus Arteriosus, Patent

ArticleYear
The pharmacology of the ductus arteriosus.
    Pharmacological reviews, 1998, Volume: 50, Issue:1

    Topics: Animals; Arachidonic Acids; Calcium; Carbon Monoxide; Cyclooxygenase Inhibitors; Ductus Arteriosus;

1998

Other Studies

3 other studies available for carbon monoxide and Ductus Arteriosus, Patent

ArticleYear
Role of microsomal prostaglandin E synthase-1 (mPGES1)-derived PGE2 in patency of the ductus arteriosus in the mouse.
    Pediatric research, 2008, Volume: 64, Issue:5

    Topics: Animals; Carbon Monoxide; Cyclooxygenase Inhibitors; Dinoprostone; Ductus Arteriosus; Ductus Arterio

2008
Interactions between NO, CO and an endothelium-derived hyperpolarizing factor (EDHF) in maintaining patency of the ductus arteriosus in the mouse.
    British journal of pharmacology, 2007, Volume: 151, Issue:1

    Topics: Animals; Biological Factors; Bradykinin; Carbon Monoxide; Ductus Arteriosus, Patent; Heme Oxygenase

2007
Transfer factor for carbon monoxide before and after surgical correction of atrial septal defect. Preliminary report.
    Annales chirurgiae et gynaecologiae Fenniae, 1968, Volume: 57, Issue:2

    Topics: Adolescent; Adult; Carbon Monoxide; Diffusion; Ductus Arteriosus, Patent; Female; Heart Septal Defec

1968